Cite
Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing.
MLA
Jihyun Chung, et al. “Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing.” Journal of Biological Chemistry, vol. 288, no. 49, Dec. 2013, pp. 35534–47. EBSCOhost, https://doi.org/10.1074/jbc.M113.510669.
APA
Jihyun Chung, Karkhanis, V., Sookil Tae, Fengting Yan, Smith, P., Ayers, L. W., Agostinelli, C., Pileri, S., Denis, G. V., Baiocchi, R. A., & Sif, S. (2013). Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing. Journal of Biological Chemistry, 288(49), 35534–35547. https://doi.org/10.1074/jbc.M113.510669
Chicago
Jihyun Chung, Vrajesh Karkhanis, Sookil Tae, Fengting Yan, Porsha Smith, Leona W. Ayers, Claudio Agostinelli, et al. 2013. “Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing.” Journal of Biological Chemistry 288 (49): 35534–47. doi:10.1074/jbc.M113.510669.